Our findings revealed that individuals carrying the CA/AA genotype of the BBS2 rs773862084 variant or the CT/TT genotype of the MKS1 rs199910690 variant did not exhibit an increased risk of developing CKD, irrespective of their BMI level. The gene discussed is BBS2; the disease is chronic kidney disease.